A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine

Abroad (travel likely)RecruitingPHASE3

Conditions

Vaccine-Preventable Diseases · Herpes Zoster

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangsu Province Center for Disease Control and Prevention (China), Zhenjiang, Jiangsu, China
Contact: Study coordinator (Fengcai Zhu, MM) · jscdczfc@126.com · 13951994867
Contact: Study coordinator (Pengfei Jin) · kingpfph@sina.com · 18852048896

Study leads

Fengcai Zhu, MM
Principal Investigator
Jiangsu Province Center for Disease Control and Prevention (China)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

Vaccine-Preventable Diseases · Herpes Zoster

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea · Seongnam-si, South Korea

Playing Game to Learn About Children's Vaccine Project

HPV · Vaccine-Preventable Diseases

Abroad (travel likely)Recruiting

Chandler, United States

Measles and BCG Vaccines for Mother and Child

Vaccine Preventable Disease · Measles · Mother-Infant Interaction

Abroad (travel likely)RecruitingPHASE4

Bissau, Guinea-Bissau